Your fractional CFO for owner-operated elective medicine practices on the California coast.
Injectables. Body sculpting. Surgery. Skin rejuvenation. Cosmetic dental. Each modality has different consultation-to-procedure conversion, different patient LTV, different competitive set. Most practices run one funnel for all of them — and miss which modality the funnel is actually working for.
30 minutes. Free. Written one-pager within 24 hours.
Five operational pains we hear most often
1. Patient acquisition cost has climbed and shows no sign of stopping
Allergan's Allē ecosystem, Galderma's ASPIRE, plus paid social and search platforms have driven acquisition cost for elective-medicine patients up significantly over the last 24-36 months. Practices winning the math are the ones who built referral and content-led acquisition strong enough to subsidize paid.
2. Consultation-to-procedure conversion is the lever most practices do not measure precisely
Top-quartile practices convert consultations to procedures at 65-75%. Median is closer to 40-50%. The gap is usually a combination of consultation experience, pricing transparency, and follow-up cadence — none of which most practices can isolate from their own data.
3. Multi-modality reporting hides which modality is actually profitable
Practices running injectables + body sculpting + skin + surgery + sometimes cosmetic dental usually report one combined P&L. The injectables line might be carrying the practice while the surgery line bleeds time. Or the opposite. Without per-modality unit economics, pricing and capacity decisions get made on instinct.
4. Patient reviews and before/after content are the trust currency, and they decay fast
A prospect comparing your practice to the one two blocks over is reading reviews, looking at before/afters, and checking provider credentials. A single bad review hits conversion across the board. Most practices either over-rely on RealSelf without owning their Google + Yelp surface, or vice versa.
5. The geographic competitive set is real and the moat is real
Elective-medicine patients shop locally. The practice that wins the prospects within a five-mile radius of itself wins the market. Practices that try to compete on price across a 50-mile radius almost always lose to a locally-anchored practice with sharper trust signals.
Visibility, acquisition, closing, servicing
Four operational layers, each with specific work we take off your plate.
Visibility
Three-layer audit (classical search + answer-engine + generative AI) calibrated to the elective-medicine vertical with state medical board ad-compliance awareness. AI-search query pack tuned to actual patient search behavior in your region and your modality mix. Monthly Monitor briefing tracking how you move against four named local peers — the practices within your geographic competitive set.
Acquisition
Public-surface channel diagnosis: where is your website, search, and AI visibility delivering patient attention by modality, and where is it underperforming? Buyer Alignment Audit if the patient mix you are attracting does not match the modality economics you need. Review-velocity and before/after content audit across RealSelf, Google, Yelp, and any modality-specific platforms.
Channel-by-channel CAC and payback analysis (injectables, body, skin, surgery, cosmetic dental) requires inside access to your marketing spend and attribution data. The Full Business Diagnostic gives you a framework-level read using your reported numbers; Engage and Manage retainers deliver the ongoing data-driven version.
Closing
Consultation-to-procedure conversion analysis by modality and by provider (from public surface plus the conversion data you supply). Pricing strategy review across injectables, body, surgery, and any modality-specific pricing models. Patient LTV + Cohort Model: retention curves, repeat-procedure rates, three-year value projections.
Servicing
Quarterly Buyer Alignment Audit (inside Engage and Manage) catches drift before it shows up in numbers. Monthly cohort intelligence on what peer practices are doing in modality mix, pricing transparency, follow-up cadence. The retainer tiers put a CFO-grade voice in monthly business reviews so the practice owner can focus on clinical leadership and patient care.
Time redeployed, role by role
The practice owner / lead provider
Time freed: 10-15 hrs/month on business reporting, modality-pricing decisions, ad strategy.
Redeploys to: Clinical leadership, patient care, provider development, the work the owner alone can do.
The practice manager
Time freed: Manual reporting cycles, channel performance reviews.
Redeploys to: Patient experience, staff coordination, operational quality.
The marketing / patient coordinator
Time freed: Custom reports nobody reads carefully, ad-platform compliance reviews.
Redeploys to: Actual patient communication, consultation follow-up, content strategy.
The clinical lead (RN, NP, PA)
Time freed: "What does this mean" data-interpretation requests from the owner.
Redeploys to: Patient care, training the team, protocol consistency.
Three entry points; most graduate to Monitor Plus
Buyer Alignment Audit
$3,995 one-time. Usually the right entry point for elective-medicine practices. Diagnoses whether the patient mix you are attracting matches the modality economics you need.
Customer Acquisition Audit
$2,995 one-time. Best if you specifically suspect the website and search layer is the bottleneck.
Full Business Diagnostic Pro
$17,995 one-time. For practices competing across several modalities with several competitive sets simultaneously. Decomposes into per-modality matrices.
Then most graduate to Monitor Plus ($1,200/mo) for ongoing cohort intelligence and monthly briefings — peer movement, AI visibility drift, pricing drift, sentiment, visual asset inventory, and three prioritized actions per month.